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Abstract
Background: Fungal polyketides include commercially important pharmaceuticals and food additives, e.g. the
cholesterol-lowering statins and the red and orange monascus pigments. Presently, production relies on isolation of
the compounds from the natural producers, and systems for heterologous production in easily fermentable and
genetically engineerable organisms, such as Saccharomyces cerevisiae and Escherichia coli are desirable. Rubrofusarin
is an orange polyketide pigment that is a common intermediate in many different fungal biosynthetic pathways.
Results: In this study, we established a biosynthetic pathway for rubrofusarin in S. cerevisiae. First, the Fusarium
graminearum gene encoding polyketide synthase 12 (PKS12) was heterologously co-expressed with the Aspergillus
fumigatus gene encoding phosphopantetheinyl transferase (npgA) resulting in production of YWA1. This aromatic
heptaketide intermediate was converted into nor-rubrofusarin upon expression of the dehydratase gene aurZ from
the aurofusarin gene cluster of F. graminearum. Final conversion into rubrofusarin was achieved by expression of
the O-methyltransferase encoding gene aurJ, also obtained from the aurofusarin gene cluster, resulting in a titer of
1.1 mg/L. Reduced levels of rubrofusarin were detected when expressing PKS12, npgA, and aurJ alone, presumably
due to spontaneous conversion of YWA1 to nor-rubrofusarin. However, the co-expression of aurZ resulted in an
approx. six-fold increase in rubrofusarin production.
Conclusions: The reconstructed pathway for rubrofusarin in S. cerevisiae allows the production of a core scaffold
molecule with a branch-point role in several fungal polyketide pathways, thus paving the way for production of
further natural pigments and bioactive molecules. Furthermore, the reconstruction verifies the suggested pathway,
and as such, it is the first example of utilizing a synthetic biological “bottom up” approach for the validation of a
complex fungal polyketide pathway.
Keywords: Iterative polyketide synthase, Pigment, Heterologous production, YWA1, Nor-rubrofusarin, Aurofusarin
Background
Polyketides exhibit large structural diversity and have
attracted considerable interest from the pharmaceutical
industry as they form a chemical class rich in bioactive
molecules. The biological activities of fungal polyketides
span from potent carcinogenic toxins (aflatoxin) over
immunosuppressants (dalesconols), anti-tumor com-
pounds (aspergiolide A) to block-buster cholesterol-
lowering drugs (statins) [1-3]. In addition, many fungal
polyketides also display vibrant colors due to their
polyaromatic structures, which have made them attract-
ive for the textile and food industries as natural
dyes [4,5].
Fungal polyketides of commercial interest are often pro-
duced in nature by species that are not easily cultured in
standard liquid fermentation setups, due to their filament-
ous growth, and formation of dense mycelium clumps
resulting in increased viscosity and reduced oxygen solu-
bility. The transfer of such biosynthetic pathways to
standard industrial cell factories, such as Saccharomyces
cerevisiae, could offer an attractive alternative as it would
allow easier fermentation and process optimization via
the existing metabolic engineering strategies. However,
only a few examples of successful heterologous expression
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of genes encoding fungal polyketide synthases in yeast
have been reported in literature. These include the 6-
MSA synthase gene from Penicillium patulum resulting
in 6-methylsalicylic acid (6-MSA) production [6-8], rdc1/
rdc5 from Pochonia chlamydosporia [9] resulting in (R)-
monocillin II production, and hpm3/hpm8 resulting in
hypothemycin production [10]. Most recently the individ-
ual expression of three PKSs from Chaetomium globosum
and one from Coprinopsis cinerea was reported in an ef-
fort to characterize orphan PKSs [11]. These results show
that yeast heterologous expression can provide an avenue
for production of industrially relevant polyketides and for
characterizing orphan polyketide synthase genes from
non-model organisms. However, common for these exam-
ples is that the studies only aimed to produce the first
stable intermediate in the respective biosynthetic pathway
and have not included the heterologous expression of any
tailoring enzymes responsible for modification of the syn-
thase product. To test the feasibility of using yeast for
production of complex polyketides we aimed to recon-
struct a fungal polyketide pigment biosynthetic pathway,
which leads to the formation of rubrofusarin (Figure 1).
Rubrofusarin is an orange-brown pigment produced by a
wide range of different fungal species, such as Fusarium
graminearum, Aspergillus niger, Aspergillus parasiticus
and Ustilaginoidea virens [12-14]. The biological activity
of rubrofusarin is reported to include inhibition of human
DNA topoisomerase II-α [15] and general antibiotic ef-
fects on Mycobacterium tuberculosis and various filament-
ous fungi [16]. Interestingly, the fate of this polyketide
core scaffold differs in the particular fungal species due to
their unique repertoires of tailoring enzymes, resulting in
production of such different end products as rubrofusarin
B, aurofusarin, nigerone, nigerasperone A, chaetochromin,
ustilaginoidin and parasperone A [12,17].
Currently, the best described biosynthetic pathway,
which includes rubrofusarin as an intermediate, is the
aurofusarin pathway in F. graminearum. In this species,
the first stable pathway intermediate on the path to
rubrofusarin is the yellow naphthopyrone YWA1, which is
synthesized by the condensation of one acetyl-CoA and
six malonyl-CoA molecules, catalyzed by the type I itera-
tive non-reducing PKS12 [18]. Similar reactions have been
reported for Aspergillus nidulans [19]. The formed YWA1
is dehydrated by AurZ to form the orange pigment nor-
rubrofusarin, which is then O-methylated by AurJ to
yield rubrofusarin (Figure 1) [12,18]. Polyketide biosyn-
thetic pathways are typically encoded by gene clusters
in fungi and mapping of the aurofusarin pathway in
F. graminearum has therefore primarily been based
on targeted deletion of the genes surrounding PKS12
[12,18,20]. Thus, the possibility exists that genes located
elsewhere in the genome might be directly involved in
the formation of rubrofusarin. Hence, an appropriate
bottom-up proof of the sole involvement of PKS12, aurZ
and aurJ in rubrofusarin formation would be their heter-
ologous expression in a phylogenetically distant organism.
Heterologous production in S. cerevisiae of other im-
portant compound classes with a complex biosynthetic
origin, e.g. terpenoids [21] and plant type III polyketides
[22], has already been well established. To provide a
proof-of-concept that this approach is also a viable op-
tion for polyketide pathways with a fungal origin, and
to prove the proposed biosynthetic pathway, we here
present the stepwise construction of a rubrofusarin path-
way in the heterologous host S. cerevisiae.
Results and discussion
Rubrofusarin has previously been described to have anti-
fungal properties, and to avoid problems with toxic effects
of intermediates or the end-product during strain con-
struction, the open reading frame (ORF) encoding the
wild type PKS12 was placed under control of the indu-
cible CUP1 promoter to allow control of expression onset
and strength. Codon optimized ORFs for aurZ, aurJ and
npgA were expressed using unique constitutive promoters
and terminators (Table 1). The genes were inserted indi-
vidually into different plasmids, derived from pRS413-6
[23], each carrying unique auxotrophic selection marker
genes along with the unique promoter and terminator ele-
ments. This plasmid-based approach was chosen to allow
for easy construction of any desired combination of genes
in S. cerevisiae to study the sequential order of individual
catalytic steps in the biosynthetic pathway (Table 1).
Heterologous production of YWA1
Expression of PKS12 and npgA in S. cerevisiae resulted
in the production of a yellow pigment which was not
seen in the control strain carrying empty plasmids. In
contrast to plates without added copper, yellow-colored
Figure 1 The rubrofusarin biosynthetic pathway. Biosynthetic pathway of rubrofusarin in F. graminearum established by targeted gene
deletion experiments [12,18].
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pigment was visually observed after approx. 24 hours
of cultivation on synthetic complete (SC) agar plates
supplemented with copper. Following incubation for an
additional 2-3 days, a yellow pigment became visible in
the medium surrounding the S. cerevisiae colonies, indi-
cating that the produced pigment was escaping from the
cells. In SC liquid cultures a yellow color became visu-
ally observable after 2-3 days of cultivation (Figure 2).
Chemical analysis, using LC-MS, of the growth medium
from the induced PKS12/npgA strain revealed a new
peak with a retention time (RT) of 5.3 min and a [M+H]+
of 277.07 m/z. Based on the exact mass, the compound
was identified as the pigment YWA1 (Figure 3). The
intensity of the peak was, however, relatively weak
suggesting either a low production level, poor extrac-
tion or ionization of YWA1, or rapid degradation as
was previously reported by Fujii and colleagues working
with YWA1 in A. oryzae [24]. This compound is also
known from Aspergillus fumigatus in which it is converted
to 1,8-dihydroxynaphthalene (DHN) in multiple steps,
including a chain-shortening reaction catalyzed by
Ayg1 [25], and in A. nidulans where it is the precursor
for the green conidial pigment [19].
Heterologous production of nor-rubrofusarin
Introduction of the dehydratase-encoding aurZ gene in
the YWA1-producing strain resulted in colonies that visu-
ally appeared more intensely orange after 3 days of cul-
tivation as compared to the parent YWA1-producing
PKS12/npgA strain (Figure 2). The yellow pigment ob-
served in the plate medium surrounding S. cerevisiae
colonies of the PKS12/npgA strain was no longer vis-
ible, suggesting conversion of YWA1 into another or-
ange pigment, which did not readily escape the cells
(Figure 2).
Chemical analysis revealed a single new peak with a
RT of 10.0 min and a [M +H]+ = 259.06 m/z which
displayed a distinct UV absorption spectrum (see UV
spectrum in Additional file 1). Based on a comparison
to nor-rubrofusarin extracted from a nor-rubrofusarin-
accumulating F. graminearum ΔaurJ reference strain,
and by comparison to a previously published UV spectrum,
the compound was identified as nor-rubrofusarin (Figure 3)
[18]. Nor-rubrofusarin could be detected in both the cell
pellet and growth medium, while YWA1 was still only
detectable in the growth medium, further indicating that
the observed change in colour is linked to the compounds
of the identified peaks (Figure 4). A low level of nor-
rubrofusarin was also detected in the cell pellet of the
PKS12/npgA parent strain likely resulting from spontan-
eous conversion of YWA1. Spontaneous dehydration of
YWA1 and YWA1-like compounds has previously been
observed with purified compounds [18,26].
Heterologous production of rubrofusarin
Introduction of aurJ, encoding an O-methyltransferase,
into the S. cerevisiae PKS12/npgA/aurZ strain changed
the visual phenotype to appear less orange during growth
on plates (strain PKS12/npgA/aurZ/aurJ, Figure 2). Chem-
ical analysis showed that nor-rubrofusarin was no longer
accumulating. Instead, a new compound accumulated
which had a RT of 13.3 min, [M +H]+ of 273.07 m/z and
a unique UV absorption spectrum (see UV spectrum
in Additional file 1). The compound was identified as
rubrofusarin by comparison to rubrofusarin extracted
from a rubrofusarin-accumulating F. graminearum ΔaurF
reference strain (Figure 3) and by comparison to the pre-
viously published UV spectrum for rubrofusarin [18]. The
rubrofusarin could be detected both in the extracted
cell pellet and growth medium. YWA1 was still measur-
able in the growth medium, however at a reduced level
(Figure 4A).
Surprisingly, introduction of aurJ in the PKS12/npgA
strain resulted in colonies that were more orange than
the PKS12/npgA strain which solely accumulates YWA1
(Figure 2). Chemical analysis showed the production of
rubrofusarin, evidenced by the appearance of a peak at
the same RT and [M+H]+ = 273.07 m/z as in the PKS12/
Table 1 S. cerevisiae strains used in the study
Strain Plasmids carried Relevant genotype
S. cerevisiae
control
pRS416 (URA3) -
pRS413 (HIS3)
pRS414 (TRP1)
pRS415 (LEU2)
S. cerevisiae
PKS12/npgA
pRS416::pCUP1-PKS12-tADH1, PKS12, npgA
pRS413::pPYK1-npgA-tTEF1
pRS414
pRS415
S. cerevisiae
PKS12/npgA/aurZ
pRS416::pCUP1-PKS12-tADH1, PKS12, npgA,
aurZ
pRS413::pPYK1-npgA-tTEF1
pRS414::pTEF1-aurZ-tENO2
pRS415
S. cerevisiae
PKS12/npgA/aurJ
pRS416::pCUP1-PKS12-tADH1, PKS12, npgA,
aurJ
pRS413::pPYK1-npgA-tTEF1
pRS415::pGPD1-aurJ-tCYC1
pRS414
S. cerevisiae
PKS12/npgA/aurZ/aurJ
pRS416::pCUP1-PKS12-tADH1, PKS12, npgA, aurZ,
aurJ
pRS413::pPYK1-npgA-tTEF1
pRS414::pTEF1-aurZ-tENO2
pRS415::pGPD1-aurJ-tCYC1
S. cerevisiae strains that were analyzed for production of rubrofusarin and
precursors. Final plasmids transformed into S. cerevisiae strains showing the
vector backbone in which the constructed promoter (p) – ORF – terminator (t)
gene cassettes were inserted. The auxotrophic marker gene is also shown. All
plasmids were maintained by the low copy number sequences ARS/CEN.
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npgA/aurZ/aurJ strain, but at an approx. six-fold lower
level. These results are contrary to what has previous-
ly been observed in F. graminearum ΔaurZ mutants
which only accumulate YWA1 even though they still
express aurJ [18]. However, as we observed in the
PKS12/npgA strain, low levels of YWA1 may undergo
spontaneous conversion to nor-rubrofusarin, and sub-
sequent methylation of this by AurJ may then explain
the formation of rubrofusarin without the presence of
AurZ. The difference in rubrofusarin concentration ob-
served between the PKS12/npgA/aurZ/aurJ and PKS12/
npgA/aurJ strains shows that AurZ is responsible for
catalyzing the specific dehydration of YWA1 to yield
nor-rubrofusarin, as previously suggested [18]. It is
noteworthy that no methylated YWA1 was observed in
the PKS12/npgA/aurJ strain at [M + H]+ = 291.08 m/z,
+ aurJ
+ aurZ
n.d.
+ PKS12
Control
PKS12/
npgA
PKS12/
npgA/
aurZ
PKS12/
npgA/
aurZ/
aurJ
PKS12/
npgA/
aurJ
Co
nt
ro
l
PK
S1
2/n
pg
A
PK
S1
2/p
gA
/
au
rZ PK
S1
2/n
pg
A/
au
rZ
/au
rJ
PK
S1
2/n
pg
A/
au
rJ
A
B Rubrofusarin
Nor-rubrofusarin
YWA1
Rubrofusarin 
- aurZ
Figure 2 Phenotype of the constructed S. cerevisiae strains. Cultures of S. cerevisiae strains, carrying the genes shown, were grown in A) SC
medium with 300 μM CuSO4 and without uracil, histidine, tryptophan and leucine. Cells were grown for 4 days at 30°C, 160 rpm shaking, and
collected by centrifugation. B) SC agar plates with 500 μM CuSO4 and without uracil, histidine, tryptophan and leucine. Grown for 4 days at 30°C.
The strains accumulated the indicated rubrofusarin pathway products.
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suggesting that formation of rubrofusarin only proceeds
through the nor-rubrofusarin intermediate, as previ-
ously proposed by Frandsen et al [12].
The presented heterologous production of rubrofusarin
supports the biosynthetic pathway suggested by Frandsen
et al. 2011 i.e. that PKS12, AurZ, and AurJ are stepwise
responsible for formation of YWA1, nor-rubrofusarin,
and rubrofusarin, respectively. In addition, it rules out the
possibility that further, as yet unidentified enzymes are re-
quired for completion of the pathway.
The accumulated rubrofusarin from the strains PKS12/
npgA/aurZ/aurJ and PKS12/npgA/aurJ was quantified by
HPLC. Integration of rubrofusarin peaks from strain cul-
ture extracts showed a titer of 1.1 mg/L rubrofusarin
produced by the PKS12/npgA/aurZ/aurJ strain, while
0.19 mg/L rubrofusarin was measured in the strain ex-
tract, when AurZ was excluded from the pathway.
In the present study no optimization strategies for
production were employed. However, several simple
optimization strategies would be applicable, such as in-
creasing the gene copy number, tuning the individual ex-
pression level of pathway enzymes, and increasing the
acetyl-CoA and malonyl-CoA precursor pools in the cell.
In addition, optimizing the fermentation conditions is
likely to substantially increase the titer. Production of
cell pigmentation would provide a simple and conveni-
ent read-out for successful optimization.
The structurally simpler polyketide 6-MSA has pre-
viously been heterologously produced in S. cerevisiae
reaching a titer of 1.7 g/L [6]. In another study, the 6-MSA
titer was increased 60% by increasing the malonyl-CoA
supply, via overexpression of the acetyl-CoA carboxylase
ACC1, reaching a final 554 mg/L with their particular
strain background [8]. These results suggest that the po-
tential for rubrofusarin production in yeast may be signifi-
cantly higher than what we detected in this pathway
reconstruction study.
S. cerevisiae as a heterologous host for fungal natural or
synthetic polyketide pathways
Simple eukaryotic hosts, such as the unicellular yeast
S. cerevisiae, hold great potential for expression and study
of heterologous biosynthetic pathways, including those of
entire gene clusters typical of secondary metabolism of
filamentous fungi. In synthetic biology terms, S. cerevisiae
represents a more “minimal host” than filamentous fungi,
due to the absence of any significant endogenous sec-
ondary metabolites [27], which could otherwise result in
pleiotropic effects, complicating product formation and
the ensuing characterization of the heterologous path-
ways. Hence, a yeast-based system for heterologous ex-
pression of fungal polyketide biosynthetic pathways is
very well-suited for efficient characterization of the con-
tinuously increasing pool of orphan fungal polyketide
Figure 3 Chemical analysis of strains. Extracted ion chromatograms (EIC) for the analyzed strains. EIC for A) S. cerevisiae PKS12/npgA/aurZ/aurJ,
growth medium (GM), B) S. cerevisiae PKS12/npgA/aurJ, (GM), C) rubrofusarin-accumulating reference F. graminearum ΔaurF, D) S. cerevisiae PKS12/
npgA/aurZ, cell pellet, E) nor-rubrofusarin-accumulating reference F. graminearum ΔaurJ, F) S. cerevisiae PKS12/npgA (GM), G) Control S. cerevisiae
strain with empty plasmids (GM). Note that the scales on the Y-axes are not identical between the different chromatograms.
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Figure 4 Detection of intermediates inside and outside of the cells. Detection of the rubrofusarin pathway intermediates in the constructed
S. cerevisiae strains, shown by mean areas of the integrated peaks from extracted ion chromatograms for A) YWA1, B) Nor-rubrofusarin, and
shown by mean titer (mg/L) calculated for C) Rubrofusarin. Measurements performed for the analyzed cell pellet (C) and growth medium (GM) of
the constructed S. cerevisiae strains (see Table 1). Error bars indicate the std. deviation of each integrated peak (n = 3). Note that the mean areas
are not comparable between different compounds.
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gene clusters being revealed by genome sequencing pro-
jects [28,29].
Reconstruction of the rubrofusarin pathway further
opens the door for heterologous production of a diver-
sity of related, but novel polyketides in S. cerevisiae, for
example by co-expressing combinations of tailoring en-
zymes such as p450s, glycosyl-, acyl- and prenyl- trans-
ferases etc. selected from other secondary metabolite
pathways and gene clusters. The genes of such enzymes
could efficiently be laid “on top” of the rubrofusarin
pathway for example by random assembly and expres-
sion on yeast artificial chromosomes [22]. The readily
observable phenotype of the developed rubrofusarin-
producing strain may also serve as a tool for optimizing
yeast for general polyketide production, e.g. via en-
hanced precursor supply or screening for optimized en-
zymes such as PPTases.
Conclusions
S. cerevisiae was engineered to produce the orange-brown
polyketide pigment rubrofusarin, a common intermediate
in a range of biosynthetic pathways found in different fila-
mentous fungal species, by introduction of the three F.
graminearum genes PKS12, aurZ and aurJ together with
the PKS-activating PPTase gene npgA. A titer of 1.1 mg/L
rubrofusarin was detected. The biosynthetic reconstruc-
tion further provides the evidence that PKS12 is respon-
sible for formation of the pigment YWA1, whereas AurZ
catalyzes the formation of the pigment nor-rubrofusarin
from YWA1. The results confirm the previously proposed
biosynthetic pathway for the formation of rubrofusarin
using a bottom-up approach and show that no other en-
zymes are necessary. The study also demonstrates that it
is possible to produce complex fungal polyketide products
in S. cerevisiae, which opens up for the industrial produc-
tion of a diversity of active and commercially interesting
polyketides in the future.
Materials and methods
Strains
Molecular cloning was performed using Escherichia coli
XL1 Blue, E. coli XL10 Gold (Stratagene) and E. coli
DH5α (Invitrogen) competent cells. Final plasmids car-
ried by strains in the chemical analysis are listed in
Table 1. All S. cerevisiae strains constructed had the
original genotype mat α, trp1Δ, lys2Δ0, leu2Δ, his3Δ1,
ura3Δ0, arg4::loxP and were derived from S. cerevisiae
BY4742 (Euroscarf ). The constructed strains are listed
in Table 1.
Enzymes and oligonucleotides
All restriction enzymes were purchased from New England
Biolabs. Oligonucleotides for subcloning and mutagen-
esis of PKS12 were synthesized by Microsynth AG, while
oligonucleotides for the USER friendly cloning were syn-
thesized by Integrated DNA Technologies.
Design and synthesis of genes
A wild type F. graminearum PH1 PKS12 ORF was
constructed using USER friendly cloning [30] by the as-
sembly of the six exons predicted by MIPS [31] [FGDB:
FGSG_02324] into the recipient vector BGHA-P1 [32]
with in vivo ligation in E. coli. All exon fragments were
PCR amplified from F. graminearum PH1 genomic
DNA using primers designed with the PHUSER web tool
(see oligonucleotides in Additional file 1) [33]. An in-
ternal HindIII restriction site in the ORF was silently
mutated by mixing approx. 200 ng plasmid harboring
the gene with 10 nmol of the primer Mut1Fwd and 10 -
nmol Mut1Rev in an otherwise standard 50 μL PCR
mixture using iProof DNA polymerase and HF Buffer
(BioRad) as the manufacturer specifies. The reaction was
PCR thermocycled for 18 cycles followed by addition of
1 μL DpnI and 3 hours of incubation at 37°C to degrade
the dam methylated original (non-mutated) plasmid
strands. 2 μL reaction was transformed into 25 μL E. coli
XL10 Gold competent cells and plasmids isolated with
QIAprep Miniprep (Qiagen). A correctly mutated plasmid
was subsequently validated by the absence of HindIII
digestion.
The AurZ [FGDB: FGSG_02326] and AurJ [FGDB:
FGSG_02325] protein sequences from F. graminearum
PH1 were used for synthesizing the two gene ORFs with
verification by sequencing and proprietary “GeneGPS”
codon optimization for S. cerevisiae by DNA2.0. The
A. fumigatus npgA gene [GenBank: XM_750100.1] was
synthesized by DNA2.0 with codon-optimization for S.
cerevisiae and verification by sequencing.
Cloning of ORFs in pRS vectors
A set of pRS vectors [31] were used in which a unique
AscI site had been inserted between the two PvuII sites,
thus replacing the original multi-cloning site. All ORFs
were subcloned with HindIII and SacII into vectors
containing the respective, constitutive promoters and ter-
minators (specified in Table 1) to form vectors with gene
cassettes. The PKS12 was provided with flanking HindIII
and SacII restriction sites by PCR with iProof DNA poly-
merase using primers PKS12Fwd and PKS12Rev (see
Additional file 1). All cassettes were subsequently cloned
into the specified pRS plasmids (Table 1) with AscI. All
ligations were performed using T4 DNA Ligase (New
England Biolabs) and confirmed by sequencing (Microsynth).
The pRS plasmids each harbour a unique auxotrophic
marker gene (Table 1) and the ARS/CEN sequences for
stable maintenance in S. cerevisiae at approx. one copy
per cell, thus allowing strain-to-strain comparability. The
PKS12 ORF was controlled by the inducible CUP1 promoter,
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which is induced from its low basal expression level by
addition of Cu2+ to the medium [34].
Transformation of S. cerevisiae strains
The S. cerevisiae strains (Table 1) were constructed by
transformation with the specified plasmids (Table 1)
according to the protocol described by Gietz & Schiestl,
2007 [35]. Transformants were plated on selective syn-
thetic complete (SC) agar plates lacking the appropriate
supplements uracil, histidine, tryptophan and leucine.
Cultivation of the S. cerevisiae strains
The S. cerevisiae strains were grown for characterization
on 2% agar plates with selective SC medium plus 500 μM
CuSO4 for induction at 30°C. For chemical analysis, the
strains were cultured by inoculating 5 mL selective SC
medium from single colonies. These pre-cultures were in-
cubated overnight at 30°C, with 160 rpm horizontal shak-
ing. Main cultures of 10 mL selective SC medium, plus
300 μM CuSO4 for induction, were inoculated from the
pre-cultures to an OD600 = 0.10 in three replicates of each
pre-cultured strain. The main cultures were incubated for
96 hours at 30°C with 160 rpm horizontal shaking.
Cultivation of reference F. graminearum strains
The reference F. graminearum strains ΔaurZ, ΔaurJ and
ΔaurF were grown on Potato Dextrose Agar (Difco) plates
at 20°C for 7 days.
Chemical extraction and LC-MS analysis
Cells and growth medium of the main cultures were sepa-
rated by centrifugation. The cells were resuspended in
1 mL dH2O and extracted by vigorous shaking with 5 mL
extraction solvent (methanol:dichloromethane:ethyl acet-
ate (1:2:3) + 1% formic acid). The mixtures were sonicated
for 1 hour in an ultrasonic bath, centrifuged, filtered
through filter paper and dried in a SpeedVac. Eight mL
of the growth medium were extracted by vigorous shaking
with 10 mL extraction solvent after which the organic
phases were dried in a SpeedVac. Three 10 mm plugs were
cut out of the mycelium of each reference F. graminearum
strain. The plugs of each replicate were mashed in 10 mL
ethyl acetate and shaken vigorously to facilitate extraction.
The organic phase was recovered following centrifugation
and filtering, at which point it was dried in a SpeedVac.
The extractions from the F. graminearum reference
strains were performed in triplicates.
All samples were reconstituted in 150 μL dimethyl
sulfoxide. Five μL was injected and analyzed by LC-
UV/ELSD on a Waters Acquity UPLC (Waters Corpor-
ation, Milfords, MA, USA), running a gradient of mobile
phases A (water + 0.1% formic acid) and B (acetonitrile +
0.1% formic acid), going from 1 to 100% B in 15 min,
flow rate of 0.4 mL/min. The column was a Waters
Acquity BEH C18 (2.1 mm× 100 mm× 1.7 μm (Waters
Corporation, Milfords, MA, USA) temperature-controlled
at 35°C. Liquid chromatography was coupled to a Bruker
Daltronics microQTOF II (Bruker Daltonics, Bremen,
Germany) using electrospray ionization source in positive
mode: End plate Offset: -500 V, Capillary voltage: 4500 V,
Nebulizer: 1.6 Bar, Dry Gas: 8.0 L/min, Dry temperature:
180°C. Extracted ion chromatograms for YWA1 (m/z
277.0707 ± 0.01), nor-rubrofusarin (m/z 259.0601 ± 0.01)
and rubrofusarin (m/z 273.0753 ± 0.01) were created
using the Bruker DataAnalysis 4.0 software. The integra-
tion of the peaks was performed with the DataAnalysis
Integrate functions (with default settings).
Quantification of rubrofusarin production
Cells and growth medium from 8 mL main culture were
separated by centrifugation. The cell pellet was resuspended
in 1 mL dH2O and 5 mL ethyl acetate. The cell pellet solu-
tion was sonicated for 30 min. in an ultrasonic bath
followed by vigorous shaking. The growth medium super-
natant was shaken vigorously with 8 mL ethyl acetate. The
ethyl acetate phases of growth medium and cell pellet were
collected individually and allowed to evaporate in a fume
hood. The extracted compounds of growth medium and
cell pellet were reconstituted in 1.5 mL and 1.0 mL metha-
nol, respectively. A rubrofusarin standard, purified from F.
graminearum, was purchased from BioViotica Naturstoffe
GmbH (Liestal, Switzerland) and reconstituted to 1 mg/mL
in dimethyl sulfoxide. A standard curve was prepared by
dissolving the rubrofusarin standard in methanol in a range
from 4 μg/mL to 10 μg/mL. Twenty μL of each standard
concentration and the extracted samples were analyzed by
HPLC using an Ascentis C18 column (particle size: 5 μm,
length × I.D.: 15 cm × 4.6 mm) (Sigma-Aldrich) running a
gradient of mobile phases C (10 mM ammonium formate
pH 3.0) and D (acetonitrile) at a flow rate of 1 mL/min,
starting at 25% D (0-3 min), going to 80% D (3-15 min),
remaining at 80% D (15-16 min), going to 25% D (16-
18 min) and remaining at 25% D (18-20 min).
Additional file
Additional file 1: Oligonucleotides, UV spectra and HPLC
chromatograms.
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